Fiat Chrysler Automobiles NV has agreed to pay up to $884 million to settle claims that it illegally equipped diesel fuel-powered vehicles with software that enabled them to cheat emissions standards.
A BakerHostetler partner who represents Endo Pharmaceuticals Inc. in multidistrict litigation over the opioid epidemic should be disqualified from the case, according to a motion filed in Ohio federal court Wednesday.
Top plaintiffs attorneys in multidistrict litigation over the opioid crisis are savaging an ethics complaint lodged by drug companies, accusing them of meritless and “dishonest” objections to televised criticism of painkiller sellers.
A Rhode Island woman's decadelong fight against CBS, among other companies, over her husband's death from an asbestos-related illness belongs in federal court, a district judge ruled Wednesday, denying her request to have the case sent back to state court.
A Connecticut state judge on Tuesday dismissed suits brought by 37 municipalities targeting Purdue Pharma and other companies over the opioid crisis for lack of jurisdiction, saying social problems do not necessitate compensatory damages.
An Illinois federal judge on Wednesday refused to narrow class definitions in a lawsuit by drivers who say their Jeeps are vulnerable to hacking, saying the automaker is trying to relitigate arguments he had already rejected at the class certification stage.
The NFL on Wednesday withdrew an explosive appeal in the landmark concussion settlement that had outraged attorneys representing the brain-damaged players covered by the deal, just one day before it was to be discussed at a much-anticipated hearing in Pennsylvania federal court.
Arizona Attorney General Mark Brnovich has sued Mercedes-Benz USA LLC and Daimler AG under the state Consumer Fraud Act, alleging the auto company and engine manufacturer sold diesel vehicles as being environmentally friendly while they were actually producing emissions at as much as 30 times the national standard.
The full Federal Circuit on Wednesday said it won’t reconsider denying National Childhood Vaccine Injury Act relief to a family whose son developed a seizure syndrome after being vaccinated, despite strong objections from two judges who accused colleagues of undermining the act’s purpose.
In an eleventh-hour move, former Insys Therapeutics Inc. CEO Michael Babich admitted to taking part in a scheme to bribe doctors into prescribing the company’s pricey fentanyl spray in Massachusetts federal court Wednesday and will cooperate as the criminal trial of his former co-workers kicks off later this month.
The application of Rhode Island law may defeat a Texas attorney's attempts to force into arbitration a dispute with a couple accusing him of botching their medical malpractice case, a First Circuit panel suggested during oral arguments Wednesday.
Tesla wrongly removed a device meant to limit the top speed of one of its 2014 Model S cars, which — combined with a flawed battery pack design — contributed to the deaths of two Florida teens in a crash last year, according to a complaint filed Tuesday in Broward County court.
The Pennsylvania federal court overseeing the landmark NFL concussion settlement provided the first in-depth look at how it's handling dozens of contentious attorney lien disputes on Monday, in a lengthy ruling that laid down general guidelines while resolving three separate disputes.
Sporting goods maker Outdoor Sports Gear Inc. on Monday urged the Ninth Circuit to reverse a district court ruling that saddled it with costs for homeowners’ asbestos-related claims, arguing that the lower court should not have departed from a previous order in a coverage fight with the company’s buyer.
A Delaware federal magistrate judge on Tuesday recommended trimming some claims as time-barred in a proposed class action against Fiat Chrysler that alleges a defect in certain Chrysler and Dodge vehicles caused tires to corrode or deflate.
A New Jersey-based chemical company on Tuesday urged the Third Circuit to undo a finding that its consumer fraud claims against two fire suppression system makers actually fell under product liability law, arguing the $5 million in damages it incurred from an explosion stemmed from the companies' false claims about the effectiveness of a fire alarm.
A Pennsylvania federal judge has recused himself out of an "abundance of caution" from an environmental contamination dispute after disclosing that his son received a job offer from BakerHostetler, which represents the steel business in the case.
A South Korean musician and actor has pressed ahead with allegations that Tesla sold vehicles that suddenly accelerated without warning and hit the electric automaker with new claims of slander and defamation for suggesting he used his celebrity status to gain a payout, according to an amended complaint filed in California federal court Monday.
The Delaware Supreme Court affirmed a $5.7 million award Monday in favor of Clean Harbors Inc. and against Union Pacific Corp. over an environmental cleanup at a Kansas waste facility, saying a potentially ambiguous jury verdict form was not, in the end, overly misleading.
Claudia Lewis, co-chair of the U.S. Food and Drug Administration practice at Venable LLP, tells Law360 that she’s eagerly awaiting an FDA definition of “natural,” chafing at new limits on homeopathic products and anticipating a nationwide policy on cannabidiol, or CBD.
2018 will be remembered as a transition year for technology-assisted review, and 2019 will likely see a continued focus on how we use TAR, with refinement and expansion across the board, says Thomas Gricks of Catalyst Repository Systems LLC.
Last year saw significant litigation over clinical trials, as well as new proposed guidance from the U.S. Food and Drug Administration about how such trials ought to be performed — guidance that could become important in future litigation, say Sheryl Bjork and William Childs of Bowman and Brooke LLP.
Last year saw another round of year-over-year growth in litigation finance, as debates shifted from whether it should be permitted to how it can best be managed. The exciting news, says Alan Guy of Vannin Capital PCC, is that 2019 seems likely to bring more of the same.
Attorneys at Faegre Baker Daniels LLP look back at the past year's most significant legal events and trends in the drug and medical device sphere, highlighting important implications for those in the industry.
The list of countries that have enacted some form of collective litigation grows longer each year. Plaintiffs attorneys are sharing information and coordinating product liability claims, and the “global class action,” in which claims are raised in different fora and discovery shared globally, is on the rise, say attorneys with DLA Piper.
Leveraging technology in a fiercely competitive market is a key factor driving law firms toward technology adoption in 2019, as they face growing demand from legal talent and clients for the ability to connect, access and control information whenever and wherever needed, says Tomas Suros of tech provider AbacusNext.
As we ring in the new year, attorneys with Alston & Bird LLP discuss what to expect from slack-fill litigation, partially hydrogenated oil-related lawsuits, and the messy regulatory landscape of cannabidiol and THC edibles.
Law360 guest authors weighed in on a host of key legal industry issues this year, ranging from in-house tips for success and open secrets about BigLaw diversity to criticisms of the equity partnership and associate salary models. Here are five articles that captured the most attention.
From talc and asbestos rulings to the Daubert standard and drug design defect litigation, it was an interesting year for product liability attorneys.
In its most significant 2018 guidance on the design, testing and deployment of driverless vehicles, the U.S. Department of Transportation articulated core regulatory principles that aim to prioritize safety, maintain technological neutrality and promote nationwide consistency, say Erika Jones and Linda Rhodes of Mayer Brown LLP.